ALLO – Allogene Therapeutics, Inc.

Allogene Therapeutics, Inc.

ALLO

$1.51

Name : Allogene Therapeutics, Inc.

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $339,342,528.00

EPSttm : -0.98

Allogene Therapeutics, Inc.

$1.51

2.58%

$0.04

Float Short %

11.71

Margin Of Safety %

Put/Call OI Ratio

0.12

EPS Next Q Diff

-0.03

EPS Last/This Y

0.38

EPS This/Next Y

0.03

Price

1.51

Target Price

7.56

Analyst Recom

1.64

Performance Q

31.3

Relative Volume

0.83

Beta

0.51

Ticker: ALLO

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-11-13	ALLO	1.195	0.74	0.21	6901
2025-11-14	ALLO	1.24	0.73	3.50	6951
2025-11-17	ALLO	1.235	0.73	0.30	6958
2025-11-18	ALLO	1.305	0.75	0.06	6890
2025-11-19	ALLO	1.27	0.75	999.99	6864
2025-11-20	ALLO	1.235	0.76	0.01	6814
2025-11-21	ALLO	1.225	0.79	0.02	6653
2025-11-24	ALLO	1.345	0.18	0.04	2427
2025-11-25	ALLO	1.36	0.16	0.00	2875
2025-11-26	ALLO	1.41	0.14	0.00	3141
2025-12-01	ALLO	1.37	0.13	0.00	3428
2025-12-02	ALLO	1.345	0.13	8.00	3496
2025-12-03	ALLO	1.515	0.13	0.03	3505
2025-12-04	ALLO	1.445	0.13	0.03	3498
2025-12-05	ALLO	1.425	0.13	0.01	3515
2025-12-08	ALLO	1.445	0.13	0.00	3544
2025-12-09	ALLO	1.42	0.13	0.47	3600
2025-12-10	ALLO	1.48	0.12	0.50	3530
2025-12-11	ALLO	1.545	0.12	0.21	3636
2025-12-12	ALLO	1.51	0.12	0.00	3666
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-11-13	ALLO	1.20	12.0	-	-0.97
2025-11-14	ALLO	1.24	17.0	-	-0.97
2025-11-17	ALLO	1.24	17.0	-	-0.97
2025-11-18	ALLO	1.30	17.0	-	-0.96
2025-11-19	ALLO	1.26	17.0	-	-0.96
2025-11-20	ALLO	1.24	17.0	-	-0.96
2025-11-21	ALLO	1.23	18.2	-	-0.96
2025-11-24	ALLO	1.35	18.2	-	-0.96
2025-11-25	ALLO	1.36	18.2	-	-0.96
2025-11-26	ALLO	1.41	18.2	-	-0.96
2025-12-01	ALLO	1.37	20.3	-	-0.94
2025-12-02	ALLO	1.34	20.3	-	-0.94
2025-12-03	ALLO	1.52	20.3	-	-0.94
2025-12-04	ALLO	1.45	20.3	-	-0.94
2025-12-05	ALLO	1.43	20.3	-	-0.94
2025-12-08	ALLO	1.45	20.3	-	-0.94
2025-12-09	ALLO	1.42	20.3	-	-0.94
2025-12-10	ALLO	1.49	20.3	-	-0.94
2025-12-11	ALLO	1.55	20.3	-	-0.94
2025-12-12	ALLO	1.51	20.3	-	-0.94
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-11-13	ALLO	-0.11	-5.29	12.26
2025-11-14	ALLO	-0.11	-5.29	12.29
2025-11-17	ALLO	-0.11	-2.70	12.29
2025-11-18	ALLO	-0.11	-2.70	12.20
2025-11-19	ALLO	-0.11	-2.70	12.20
2025-11-20	ALLO	-0.11	-2.70	12.20
2025-11-21	ALLO	-0.11	-2.70	11.98
2025-11-24	ALLO	-0.11	-9.57	11.98
2025-11-25	ALLO	-0.11	-9.57	11.98
2025-11-26	ALLO	-0.11	-9.57	11.73
2025-12-01	ALLO	-0.11	-9.56	11.73
2025-12-02	ALLO	-0.11	-9.56	11.73
2025-12-03	ALLO	-0.11	-9.56	11.73
2025-12-04	ALLO	-0.11	-9.56	11.73
2025-12-05	ALLO	-0.11	-9.56	11.73
2025-12-08	ALLO	-0.11	-9.56	11.73
2025-12-09	ALLO	-0.11	-9.56	11.73
2025-12-10	ALLO	-0.11	-9.56	11.71
2025-12-11	ALLO	-0.11	-9.56	11.71
2025-12-12	ALLO	-0.11	-9.56	11.71
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

[stock_market_widget type="chart" template="candlestick" assets="ALLO" range="1y" interval="1d" price_field="close" heading="{symbol}" candle_border_width="1" candle_bullish_background_color="#21BA45" candle_bearish_background_color="#DB2828" candle_bullish_border_color="#21BA45" candle_bearish_border_color="#DB2828" axes_color="#000000" tooltip_text_color="#262626" tooltip_background_color="#ffffff" range_selector="true" volume_enabled="true" axes_enabled="true" tooltip_enabled="false" zoom_enabled="true" save_image_enabled="true" volume_bar_fill_color="#5679FF" api="yahoo-finance"]

Last Quarter Act. EPS

-0.19

Avg. EPS Est. Current Quarter

-0.22

Avg. EPS Est. Next Quarter

-0.22

Insider Transactions

-0.11

Institutional Transactions

-9.56

Beta

0.51

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

96.1

Max Drawdown 5-Year %

-97.6

Target Price

7.56

P/E

Forward P/E

PEG

P/S

P/B

1.07

P/Free Cash Flow

EPS

-0.98

Average EPS Est. Cur. Y

-0.94

EPS Next Y. (Est.)

-0.91

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

0.83

Return on Equity vs Sector %

-94.1

Return on Equity vs Industry %

-79.1

EPS 1 7Days Diff

EPS 1 30Days Diff

0.09

EBIT Estimation

[stock_market_widget type=”table-options” template=”gradient” color=”#5679FF” assets=”ALLO” fields=”contract_symbol,type,strike,price,change_pct,implied_volatility,change_abs,open_interest,volume,in_the_money,bid,ask” pagination=”true” rows_per_page=”21″ sort_direction=”asc” alignment=”left” search=”true” sort_field=”strike” api=”yahoo-finance”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”ALLO” options_type=”calls” x_axis_field=”strike” y_axis_field=”price” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”ALLO” options_type=”puts” x_axis_field=”strike” y_axis_field=”price” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”ALLO” options_type=”calls” x_axis_field=”strike” y_axis_field=”implied_volatility” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”ALLO” options_type=”puts” x_axis_field=”strike” y_axis_field=”implied_volatility” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”ALLO” options_type=”calls” x_axis_field=”strike” y_axis_field=”volume” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”ALLO” options_type=”puts” x_axis_field=”strike” y_axis_field=”volume” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

Allogene Therapeutics, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 226

Allogene Therapeutics, Inc. a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer and autoimmune diseases. It develops, manufactures, and commercializes UCART19, an allogeneic anti-CD19 chimeric antigen receptor (CAR) T cell product candidate for the treatment of patients with R/R CD19 positive B-cell acute lymphoblastic leukemia (ALL). The company also develops cemacabtagene ansegedleucel, an engineered allogeneic CAR T cell product candidate that targets CD19 for the treatment of large B-cell lymphoma. In addition, it provides clinical-stage products, such as ALLO-501, cema-cel, ALLO-316, ALLO-329, ALLO-715, and ALLO-605; DLL3 for the treatment of small cell lung cancer; Claudin 18.2 for the treatment of gastric and pancreatic cancer; and FLT3 for the treatment of acute myeloid leukemia. The company has license and collaboration agreements with Pfizer Inc., Servier, Cellectis S.A., and Notch Therapeutics Inc. It also has a strategic collaboration agreement with The University of Texas MD Anderson Cancer Center for the preclinical and clinical investigation of allogeneic CAR T cell product candidates; and a strategic partnership with Foresight Diagnostics to develop MRD-based In-Vitro Diagnostic for use in ALPHA3. The company was incorporated in 2017 and is headquartered in South San Francisco, California.

stock quote shares ALLO – Allogene Therapeutics, Inc. Stock Price stock today

news today ALLO – Allogene Therapeutics, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch ALLO – Allogene Therapeutics, Inc. yahoo finance google finance

stock history ALLO – Allogene Therapeutics, Inc. invest stock market

stock prices ALLO premarket after hours

ticker ALLO fair value insiders trading

ALLO – Allogene Therapeutics, Inc.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: ALLO

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y